HEADER IMMUNE SYSTEM 06-FEB-15 4Y16 TITLE CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIGEN-PRESENTING GLYCOPROTEIN CD1D1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ECTODOMAIN, UNP RESIDUES 19-297; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: UNP RESIDUES 21-119; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: CHIMERIC TCR VALPHA14/JALPHA18 CHAIN (MOUSE VARIABLE COMPND 13 DOMAIN, HUMAN CONSTANT DOMAIN); COMPND 14 CHAIN: C; COMPND 15 SYNONYM: PROTEIN TRAV11D,HUMAN NKT TCR BETA CHAIN; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: CHIMERIC TCR VBETA8.2 CHAIN (MOUSE VARIABLE DOMAIN, HUMAN COMPND 19 CONSTANT DOMAIN); COMPND 20 CHAIN: D; COMPND 21 SYNONYM: BETA-CHAIN,T-CELL RECEPTOR BETA-2 CHAIN C REGION; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: CD1D1, CD1.1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBACPHP10; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_COMMON: MOUSE; SOURCE 14 ORGANISM_TAXID: 10090; SOURCE 15 GENE: B2M; SOURCE 16 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PBACP10PH; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: MUS MUSCULUS, HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: MOUSE, HUMAN; SOURCE 24 ORGANISM_TAXID: 10090, 9606; SOURCE 25 GENE: TRAV11, TRAV11D, HDCMA22P; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 27 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 28 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PET22B+; SOURCE 31 MOL_ID: 4; SOURCE 32 ORGANISM_SCIENTIFIC: MUS MUSCULUS, HOMO SAPIENS; SOURCE 33 ORGANISM_COMMON: MOUSE, HUMAN; SOURCE 34 ORGANISM_TAXID: 10090, 9606; SOURCE 35 GENE: TRBC2, TCRBC2; SOURCE 36 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 37 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 38 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 39 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 40 EXPRESSION_SYSTEM_PLASMID: PET22B+ KEYWDS MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, KEYWDS 2 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.M.ZAJONC,M.NEMCOVIC REVDAT 9 27-SEP-23 4Y16 1 HETSYN LINK REVDAT 8 29-JUL-20 4Y16 1 COMPND REMARK HETNAM LINK REVDAT 8 2 1 SITE ATOM REVDAT 7 11-DEC-19 4Y16 1 REMARK REVDAT 6 22-NOV-17 4Y16 1 REMARK REVDAT 5 13-SEP-17 4Y16 1 REMARK REVDAT 4 27-JUL-16 4Y16 1 REMARK REVDAT 3 22-JUL-15 4Y16 1 JRNL REVDAT 2 10-JUN-15 4Y16 1 JRNL REVDAT 1 03-JUN-15 4Y16 0 JRNL AUTH A.BIRKHOLZ,M.NEMCOVIC,E.D.YU,E.GIRARDI,J.WANG,A.KHURANA, JRNL AUTH 2 N.PAUWELS,E.FARBER,S.CHITALE,R.W.FRANCK,M.TSUJI,A.HOWELL, JRNL AUTH 3 S.VAN CALENBERGH,M.KRONENBERG,D.M.ZAJONC JRNL TITL LIPID AND CARBOHYDRATE MODIFICATIONS OF JRNL TITL 2 ALPHA-GALACTOSYLCERAMIDE DIFFERENTLY INFLUENCE MOUSE AND JRNL TITL 3 HUMAN TYPE I NATURAL KILLER T CELL ACTIVATION. JRNL REF J.BIOL.CHEM. V. 290 17206 2015 JRNL REFN ESSN 1083-351X JRNL PMID 26018083 JRNL DOI 10.1074/JBC.M115.654814 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0104 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 32773 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 971 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2240 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.3430 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.4810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6328 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 153 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.561 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.293 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.252 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6667 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9080 ; 1.248 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 803 ; 6.035 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 303 ;36.872 ;24.488 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1025 ;14.867 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;17.931 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1000 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5076 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4Y16 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000206675. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9769 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.1.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34681 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 66.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.47800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2Q7Y, 3QUZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 0.2M DI-AMMONIUM REMARK 280 HYDROGEN CITRATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 295.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.96000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.96000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.82000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 95.95700 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.82000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 95.95700 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 75.96000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.82000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 95.95700 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 75.96000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.82000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 95.95700 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 37720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 GLU A 2 REMARK 465 ALA A 3 REMARK 465 GLN A 4 REMARK 465 GLN A 5 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ALA A 200 REMARK 465 HIS A 201 REMARK 465 GLY A 202 REMARK 465 HIS A 203 REMARK 465 HIS A 280 REMARK 465 HIS A 281 REMARK 465 HIS A 282 REMARK 465 HIS A 283 REMARK 465 HIS A 284 REMARK 465 HIS A 285 REMARK 465 ILE B 1 REMARK 465 MET C -1 REMARK 465 LYS C 0 REMARK 465 SER C 182 REMARK 465 PRO C 204 REMARK 465 GLU C 205 REMARK 465 SER C 206 REMARK 465 SER C 207 REMARK 465 MET D 0 REMARK 465 GLU D 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 21 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 170 CG CD1 CD2 REMARK 470 ARG A 204 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 224 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 227 CG CD OE1 NE2 REMARK 470 GLN A 230 CG CD OE1 NE2 REMARK 470 GLU A 254 CG CD OE1 OE2 REMARK 470 TRP A 279 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 279 CZ3 CH2 REMARK 470 LYS B 3 CG CD CE NZ REMARK 470 LYS B 58 CG CD CE NZ REMARK 470 LYS C 41 CG CD CE NZ REMARK 470 ARG C 126 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 133 CG CD CE NZ REMARK 470 LYS C 151 CG CD CE NZ REMARK 470 LYS C 181 CG CD CE NZ REMARK 470 GLU C 197 CG CD OE1 OE2 REMARK 470 LYS D 129 CG CD CE NZ REMARK 470 ASP D 182 CG OD1 OD2 REMARK 470 GLU D 216 CG CD OE1 OE2 REMARK 470 GLU D 219 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 411 O HOH A 411 3654 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 20 -154.02 -149.84 REMARK 500 ASP A 166 -61.00 -109.69 REMARK 500 ASN B 42 73.62 40.02 REMARK 500 TRP B 60 -6.49 78.39 REMARK 500 SER B 86 1.14 -68.89 REMARK 500 LYS C 41 -167.22 -73.41 REMARK 500 ALA C 85 -179.83 -179.51 REMARK 500 ASP C 119 58.40 -148.31 REMARK 500 ILE D 46 -64.59 -98.23 REMARK 500 SER D 87 176.76 179.85 REMARK 500 ASP D 95 -155.70 -86.33 REMARK 500 GLN D 177 65.53 -156.67 REMARK 500 PRO D 227 61.64 -67.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4Y2D RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXES BUT CONTAINING DIFFERENT GLYCOLIPID ANTIGENS REMARK 900 RELATED ID: 4Y4F RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXES BUT CONTAINING DIFFERENT GLYCOLIPID ANTIGENS REMARK 900 RELATED ID: 4Y4H RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXES BUT CONTAINING DIFFERENT GLYCOLIPID ANTIGENS REMARK 900 RELATED ID: 4Y4K RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXES BUT CONTAINING DIFFERENT GLYCOLIPID ANTIGENS REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHIMERIC TCR VALPHA14JALPHA18 CHAIN (CHAIN C) IS MADE OF: MOUSE REMARK 999 VARIABLE DOMAIN REMARK 999 (MKTQVEQSPQSLVVRQGENCVLQCNYSVTPDNHLRWFKQDTGKGLVSLTVLVDQKDKTSNGRYSATL REMARK 999 DKDAKHSTLHITATLLDDTATYICVVGDRGSALGRLHFGAGTQLIVI) AND HUMAN CONSTANT REMARK 999 DOMAIN (PDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKS REMARK 999 NSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS) CHIMERIC TCR VBETA8.2 CHAIN REMARK 999 (CHAIN D) IS MADE OF: MOUSE VARIABLE DOMAIN REMARK 999 (MEAAVTQSPRNKVAVTGGKVTLSCNQTNNHNNMYWYRQDTGHGLRLIHYSYGAGSTEKGDIPDGYKA REMARK 999 SRPSQENFSLILELATPSQTSVYFCASGDEGYTQYFGPGTRLLVLEDLRNVTPPKVSLFEPSK) AND REMARK 999 HUMAN CONSTANT DOMAIN REMARK 999 REMARK 999 (AEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSAT DBREF 4Y16 A 1 279 UNP P11609 CD1D1_MOUSE 19 297 DBREF 4Y16 B 1 99 UNP P01887 B2MG_MOUSE 21 119 DBREF 4Y16 C -1 207 PDB 4Y16 4Y16 -1 207 DBREF 4Y16 D 0 240 PDB 4Y16 4Y16 0 240 SEQADV 4Y16 HIS A 201 UNP P11609 ASP 219 VARIANT SEQADV 4Y16 HIS A 280 UNP P11609 EXPRESSION TAG SEQADV 4Y16 HIS A 281 UNP P11609 EXPRESSION TAG SEQADV 4Y16 HIS A 282 UNP P11609 EXPRESSION TAG SEQADV 4Y16 HIS A 283 UNP P11609 EXPRESSION TAG SEQADV 4Y16 HIS A 284 UNP P11609 EXPRESSION TAG SEQADV 4Y16 HIS A 285 UNP P11609 EXPRESSION TAG SEQRES 1 A 285 SER GLU ALA GLN GLN LYS ASN TYR THR PHE ARG CYS LEU SEQRES 2 A 285 GLN MET SER SER PHE ALA ASN ARG SER TRP SER ARG THR SEQRES 3 A 285 ASP SER VAL VAL TRP LEU GLY ASP LEU GLN THR HIS ARG SEQRES 4 A 285 TRP SER ASN ASP SER ALA THR ILE SER PHE THR LYS PRO SEQRES 5 A 285 TRP SER GLN GLY LYS LEU SER ASN GLN GLN TRP GLU LYS SEQRES 6 A 285 LEU GLN HIS MET PHE GLN VAL TYR ARG VAL SER PHE THR SEQRES 7 A 285 ARG ASP ILE GLN GLU LEU VAL LYS MET MET SER PRO LYS SEQRES 8 A 285 GLU ASP TYR PRO ILE GLU ILE GLN LEU SER ALA GLY CYS SEQRES 9 A 285 GLU MET TYR PRO GLY ASN ALA SER GLU SER PHE LEU HIS SEQRES 10 A 285 VAL ALA PHE GLN GLY LYS TYR VAL VAL ARG PHE TRP GLY SEQRES 11 A 285 THR SER TRP GLN THR VAL PRO GLY ALA PRO SER TRP LEU SEQRES 12 A 285 ASP LEU PRO ILE LYS VAL LEU ASN ALA ASP GLN GLY THR SEQRES 13 A 285 SER ALA THR VAL GLN MET LEU LEU ASN ASP THR CYS PRO SEQRES 14 A 285 LEU PHE VAL ARG GLY LEU LEU GLU ALA GLY LYS SER ASP SEQRES 15 A 285 LEU GLU LYS GLN GLU LYS PRO VAL ALA TRP LEU SER SER SEQRES 16 A 285 VAL PRO SER SER ALA HIS GLY HIS ARG GLN LEU VAL CYS SEQRES 17 A 285 HIS VAL SER GLY PHE TYR PRO LYS PRO VAL TRP VAL MET SEQRES 18 A 285 TRP MET ARG GLY ASP GLN GLU GLN GLN GLY THR HIS ARG SEQRES 19 A 285 GLY ASP PHE LEU PRO ASN ALA ASP GLU THR TRP TYR LEU SEQRES 20 A 285 GLN ALA THR LEU ASP VAL GLU ALA GLY GLU GLU ALA GLY SEQRES 21 A 285 LEU ALA CYS ARG VAL LYS HIS SER SER LEU GLY GLY GLN SEQRES 22 A 285 ASP ILE ILE LEU TYR TRP HIS HIS HIS HIS HIS HIS SEQRES 1 B 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR SEQRES 3 B 99 VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET SEQRES 4 B 99 LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER SEQRES 5 B 99 ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 B 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR SEQRES 7 B 99 ALA CYS ARG VAL LYS HIS ALA SER MET ALA GLU PRO LYS SEQRES 8 B 99 THR VAL TYR TRP ASP ARG ASP MET SEQRES 1 C 209 MET LYS THR GLN VAL GLU GLN SER PRO GLN SER LEU VAL SEQRES 2 C 209 VAL ARG GLN GLY GLU ASN CYS VAL LEU GLN CYS ASN TYR SEQRES 3 C 209 SER VAL THR PRO ASP ASN HIS LEU ARG TRP PHE LYS GLN SEQRES 4 C 209 ASP THR GLY LYS GLY LEU VAL SER LEU THR VAL LEU VAL SEQRES 5 C 209 ASP GLN LYS ASP LYS THR SER ASN GLY ARG TYR SER ALA SEQRES 6 C 209 THR LEU ASP LYS ASP ALA LYS HIS SER THR LEU HIS ILE SEQRES 7 C 209 THR ALA THR LEU LEU ASP ASP THR ALA THR TYR ILE CYS SEQRES 8 C 209 VAL VAL GLY ASP ARG GLY SER ALA LEU GLY ARG LEU HIS SEQRES 9 C 209 PHE GLY ALA GLY THR GLN LEU ILE VAL ILE PRO ASP ILE SEQRES 10 C 209 GLN ASN PRO ASP PRO ALA VAL TYR GLN LEU ARG ASP SER SEQRES 11 C 209 LYS SER SER ASP LYS SER VAL CYS LEU PHE THR ASP PHE SEQRES 12 C 209 ASP SER GLN THR ASN VAL SER GLN SER LYS ASP SER ASP SEQRES 13 C 209 VAL TYR ILE THR ASP LYS CYS VAL LEU ASP MET ARG SER SEQRES 14 C 209 MET ASP PHE LYS SER ASN SER ALA VAL ALA TRP SER ASN SEQRES 15 C 209 LYS SER ASP PHE ALA CYS ALA ASN ALA PHE ASN ASN SER SEQRES 16 C 209 ILE ILE PRO GLU ASP THR PHE PHE PRO SER PRO GLU SER SEQRES 17 C 209 SER SEQRES 1 D 241 MET GLU ALA ALA VAL THR GLN SER PRO ARG ASN LYS VAL SEQRES 2 D 241 ALA VAL THR GLY GLY LYS VAL THR LEU SER CYS ASN GLN SEQRES 3 D 241 THR ASN ASN HIS ASN ASN MET TYR TRP TYR ARG GLN ASP SEQRES 4 D 241 THR GLY HIS GLY LEU ARG LEU ILE HIS TYR SER TYR GLY SEQRES 5 D 241 ALA GLY SER THR GLU LYS GLY ASP ILE PRO ASP GLY TYR SEQRES 6 D 241 LYS ALA SER ARG PRO SER GLN GLU ASN PHE SER LEU ILE SEQRES 7 D 241 LEU GLU LEU ALA THR PRO SER GLN THR SER VAL TYR PHE SEQRES 8 D 241 CYS ALA SER GLY ASP GLU GLY TYR THR GLN TYR PHE GLY SEQRES 9 D 241 PRO GLY THR ARG LEU LEU VAL LEU GLU ASP LEU ARG ASN SEQRES 10 D 241 VAL THR PRO PRO LYS VAL SER LEU PHE GLU PRO SER LYS SEQRES 11 D 241 ALA GLU ILE SER HIS THR GLN LYS ALA THR LEU VAL CYS SEQRES 12 D 241 LEU ALA THR GLY PHE TYR PRO ASP HIS VAL GLU LEU SER SEQRES 13 D 241 TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL CYS SEQRES 14 D 241 THR ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA LEU ASN SEQRES 15 D 241 ASP SER ARG TYR SER LEU SER SER ARG LEU ARG VAL SER SEQRES 16 D 241 ALA THR PHE TRP GLN ASN PRO ARG ASN HIS PHE ARG CYS SEQRES 17 D 241 GLN VAL GLN PHE TYR GLY LEU SER GLU ASN ASP GLU TRP SEQRES 18 D 241 THR GLN ASP ARG ALA LYS PRO VAL THR GLN ILE VAL SER SEQRES 19 D 241 ALA GLU ALA TRP GLY ARG ALA HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET FUL F 3 10 HET 48G A 301 73 HET NAG A 302 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM 48G N-[(2S,3S,4R)-3,4-DIHYDROXY-1-{[6-O-(NAPHTHALEN-1- HETNAM 2 48G YLCARBAMOYL)-ALPHA-D-GALACTOPYRANOSYL]OXY}OCTADECAN-2- HETNAM 3 48G YL]HEXACOSANAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE FORMUL 5 NAG 5(C8 H15 N O6) FORMUL 6 FUL C6 H12 O5 FORMUL 7 48G C61 H106 N2 O10 FORMUL 9 HOH *46(H2 O) HELIX 1 AA1 SER A 59 SER A 89 1 31 HELIX 2 AA2 PRO A 140 TRP A 142 5 3 HELIX 3 AA3 LEU A 143 ALA A 152 1 10 HELIX 4 AA4 ASP A 153 ASP A 166 1 14 HELIX 5 AA5 ASP A 166 GLY A 179 1 14 HELIX 6 AA6 GLY A 179 GLU A 184 1 6 HELIX 7 AA7 LEU C 80 THR C 84 5 5 HELIX 8 AA8 ARG C 166 ASP C 169 5 4 HELIX 9 AA9 ALA C 185 ALA C 189 5 5 HELIX 10 AB1 THR D 82 THR D 86 5 5 HELIX 11 AB2 SER D 128 GLN D 136 1 9 HELIX 12 AB3 ALA D 195 ASN D 200 1 6 SHEET 1 AA1 8 SER A 48 PHE A 49 0 SHEET 2 AA1 8 LEU A 35 TRP A 40 -1 N ARG A 39 O SER A 48 SHEET 3 AA1 8 SER A 24 LEU A 32 -1 N LEU A 32 O LEU A 35 SHEET 4 AA1 8 THR A 9 PHE A 18 -1 N LEU A 13 O VAL A 29 SHEET 5 AA1 8 ILE A 96 MET A 106 -1 O ALA A 102 N CYS A 12 SHEET 6 AA1 8 SER A 112 PHE A 120 -1 O ALA A 119 N GLN A 99 SHEET 7 AA1 8 LYS A 123 TRP A 129 -1 O VAL A 126 N VAL A 118 SHEET 8 AA1 8 SER A 132 THR A 135 -1 O GLN A 134 N ARG A 127 SHEET 1 AA2 4 VAL A 190 VAL A 196 0 SHEET 2 AA2 4 GLN A 205 PHE A 213 -1 O VAL A 207 N SER A 194 SHEET 3 AA2 4 TRP A 245 ASP A 252 -1 O LEU A 247 N VAL A 210 SHEET 4 AA2 4 HIS A 233 ARG A 234 -1 N HIS A 233 O THR A 250 SHEET 1 AA3 4 VAL A 190 VAL A 196 0 SHEET 2 AA3 4 GLN A 205 PHE A 213 -1 O VAL A 207 N SER A 194 SHEET 3 AA3 4 TRP A 245 ASP A 252 -1 O LEU A 247 N VAL A 210 SHEET 4 AA3 4 LEU A 238 PRO A 239 -1 N LEU A 238 O TYR A 246 SHEET 1 AA4 4 GLN A 227 GLU A 228 0 SHEET 2 AA4 4 TRP A 219 ARG A 224 -1 N ARG A 224 O GLN A 227 SHEET 3 AA4 4 LEU A 261 LYS A 266 -1 O ALA A 262 N MET A 223 SHEET 4 AA4 4 ILE A 275 TYR A 278 -1 O LEU A 277 N CYS A 263 SHEET 1 AA5 4 GLN B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA5 4 GLU B 50 MET B 51 -1 N GLU B 50 O HIS B 67 SHEET 1 AA6 4 GLN B 6 SER B 11 0 SHEET 2 AA6 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA6 4 PHE B 62 PHE B 70 -1 O THR B 68 N LEU B 23 SHEET 4 AA6 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA7 4 LYS B 44 LYS B 45 0 SHEET 2 AA7 4 GLU B 36 LYS B 41 -1 N LYS B 41 O LYS B 44 SHEET 3 AA7 4 TYR B 78 LYS B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 AA7 4 LYS B 91 TYR B 94 -1 O VAL B 93 N CYS B 80 SHEET 1 AA8 5 VAL C 3 SER C 6 0 SHEET 2 AA8 5 CYS C 18 TYR C 24 -1 O ASN C 23 N GLU C 4 SHEET 3 AA8 5 HIS C 71 ILE C 76 -1 O LEU C 74 N LEU C 20 SHEET 4 AA8 5 TYR C 61 ASP C 66 -1 N SER C 62 O HIS C 75 SHEET 5 AA8 5 LYS C 53 ASN C 58 -1 N ASN C 58 O TYR C 61 SHEET 1 AA9 5 SER C 9 ARG C 13 0 SHEET 2 AA9 5 THR C 107 ILE C 112 1 O ILE C 112 N VAL C 12 SHEET 3 AA9 5 ALA C 85 GLY C 92 -1 N ALA C 85 O LEU C 109 SHEET 4 AA9 5 HIS C 31 GLN C 37 -1 N PHE C 35 O ILE C 88 SHEET 5 AA9 5 VAL C 44 LEU C 49 -1 O LEU C 46 N TRP C 34 SHEET 1 AB1 4 SER C 9 ARG C 13 0 SHEET 2 AB1 4 THR C 107 ILE C 112 1 O ILE C 112 N VAL C 12 SHEET 3 AB1 4 ALA C 85 GLY C 92 -1 N ALA C 85 O LEU C 109 SHEET 4 AB1 4 LEU C 101 PHE C 103 -1 O HIS C 102 N VAL C 91 SHEET 1 AB2 8 VAL C 155 ILE C 157 0 SHEET 2 AB2 8 SER C 174 SER C 179 -1 O TRP C 178 N TYR C 156 SHEET 3 AB2 8 SER C 134 THR C 139 -1 N CYS C 136 O ALA C 177 SHEET 4 AB2 8 ALA C 121 ASP C 127 -1 N TYR C 123 O LEU C 137 SHEET 5 AB2 8 LYS D 121 GLU D 126 -1 O GLU D 126 N ARG C 126 SHEET 6 AB2 8 LYS D 137 PHE D 147 -1 O VAL D 141 N PHE D 125 SHEET 7 AB2 8 TYR D 185 SER D 194 -1 O VAL D 193 N ALA D 138 SHEET 8 AB2 8 VAL D 167 THR D 169 -1 N CYS D 168 O ARG D 190 SHEET 1 AB3 8 VAL C 155 ILE C 157 0 SHEET 2 AB3 8 SER C 174 SER C 179 -1 O TRP C 178 N TYR C 156 SHEET 3 AB3 8 SER C 134 THR C 139 -1 N CYS C 136 O ALA C 177 SHEET 4 AB3 8 ALA C 121 ASP C 127 -1 N TYR C 123 O LEU C 137 SHEET 5 AB3 8 LYS D 121 GLU D 126 -1 O GLU D 126 N ARG C 126 SHEET 6 AB3 8 LYS D 137 PHE D 147 -1 O VAL D 141 N PHE D 125 SHEET 7 AB3 8 TYR D 185 SER D 194 -1 O VAL D 193 N ALA D 138 SHEET 8 AB3 8 LEU D 174 LYS D 175 -1 N LEU D 174 O SER D 186 SHEET 1 AB4 2 LEU C 163 MET C 165 0 SHEET 2 AB4 2 PHE C 170 SER C 172 -1 O PHE C 170 N MET C 165 SHEET 1 AB5 4 VAL D 4 SER D 7 0 SHEET 2 AB5 4 VAL D 19 GLN D 25 -1 O SER D 22 N SER D 7 SHEET 3 AB5 4 ASN D 73 LEU D 78 -1 O LEU D 78 N VAL D 19 SHEET 4 AB5 4 LYS D 65 SER D 70 -1 N LYS D 65 O ILE D 77 SHEET 1 AB6 6 ASN D 10 VAL D 14 0 SHEET 2 AB6 6 THR D 106 LEU D 111 1 O ARG D 107 N LYS D 11 SHEET 3 AB6 6 SER D 87 GLY D 94 -1 N SER D 87 O LEU D 108 SHEET 4 AB6 6 ASN D 31 GLN D 37 -1 N TYR D 35 O PHE D 90 SHEET 5 AB6 6 ARG D 44 SER D 49 -1 O ILE D 46 N TRP D 34 SHEET 6 AB6 6 GLU D 56 LYS D 57 -1 O GLU D 56 N TYR D 48 SHEET 1 AB7 4 ASN D 10 VAL D 14 0 SHEET 2 AB7 4 THR D 106 LEU D 111 1 O ARG D 107 N LYS D 11 SHEET 3 AB7 4 SER D 87 GLY D 94 -1 N SER D 87 O LEU D 108 SHEET 4 AB7 4 TYR D 101 PHE D 102 -1 O TYR D 101 N SER D 93 SHEET 1 AB8 4 LYS D 161 VAL D 163 0 SHEET 2 AB8 4 VAL D 152 VAL D 158 -1 N VAL D 158 O LYS D 161 SHEET 3 AB8 4 HIS D 204 PHE D 211 -1 O GLN D 210 N GLU D 153 SHEET 4 AB8 4 GLN D 230 TRP D 237 -1 O ALA D 234 N CYS D 207 SSBOND 1 CYS A 104 CYS A 168 1555 1555 2.11 SSBOND 2 CYS A 208 CYS A 263 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 SSBOND 4 CYS C 22 CYS C 89 1555 1555 2.04 SSBOND 5 CYS C 136 CYS C 186 1555 1555 2.05 SSBOND 6 CYS C 161 CYS D 168 1555 1555 2.06 SSBOND 7 CYS D 23 CYS D 91 1555 1555 2.03 SSBOND 8 CYS D 142 CYS D 207 1555 1555 2.01 LINK ND2 ASN A 20 C1 NAG A 302 1555 1555 1.45 LINK ND2 ASN A 42 C1 NAG E 1 1555 1555 1.43 LINK ND2 ASN A 165 C1 NAG F 1 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.43 LINK O6 NAG F 1 C1 FUL F 3 1555 1555 1.46 CISPEP 1 SER A 89 PRO A 90 0 6.41 CISPEP 2 TYR A 94 PRO A 95 0 -3.72 CISPEP 3 TYR A 214 PRO A 215 0 -0.76 CISPEP 4 HIS B 31 PRO B 32 0 3.63 CISPEP 5 SER C 6 PRO C 7 0 -2.45 CISPEP 6 THR C 27 PRO C 28 0 -7.37 CISPEP 7 SER D 7 PRO D 8 0 -5.50 CISPEP 8 TYR D 148 PRO D 149 0 -6.04 CRYST1 79.640 191.914 151.920 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012557 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005211 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006582 0.00000